InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Pushkin still a poet and not a restaurant


An applicant recently filed a trade mark application for ПУШКИНЪ (Pushkin) to provide catering services. The claimed designation is an oval figure reminiscent of a frame of a painting or a mirror encircling the word element ПУШКИНЪ.

The Patent Office declined the registration, arguing that the word ПУШКИНЪ is the name of the great Russian poet Alexander Pushkin and registration of his name as a trade mark would not be in the public interest.

The applicant appealed the decision to the Chamber of Patent Disputes and argued that his restaurant – Café ПУШКИНЪ – had been operating since...


Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of one week’s FREE access and become a Managing IP member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain 7 days FREE access when you register now.

Join here

profile

Managing IP

ManagingIP

ManagingIP profile

Re @uspto @Columbia event (earlier tweet) on June 9, use the code PTOcomp-55 to save $55 on registration until June 5 http://t.co/ZgWY0Lx5sy

May 28 2015 04:58 ·  reply ·  retweet ·  favourite
ManagingIP profile

Italy to join #UnitaryPatent & other news from today's EU Competitiveness Council meeting http://t.co/0ikuv1pjTK http://t.co/YbFS88oqSF

May 28 2015 04:25 ·  reply ·  retweet ·  favourite
ManagingIP profile

RT @RMW136: Interested to hear your stories about how you encourage innovation in your businesses! https://t.co/9zLoVf9Klu

May 28 2015 04:19 ·  reply ·  retweet ·  favourite
More from the Managing IP blog


INTA Daily News 2015

Read this year's INTA Daily News - published daily by Managing IP direct from the INTA Annual Meeting in San Diego


June 2015

The fine line between abuse and fair use at the PTAB

Hedge fund manager Kyle Bass has outraged the pharma and biotech industries by seeking to invalidate their patents at the PTAB, with some observers linking his attacks to short-selling of company stocks. Michael Loney reports on a controversy that goes to the heart of the US patent system



Most read articles

Supplements